(Q80786921)
Statements
STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy (English)
Wenjun Wang
Howard D Edington
Uma N M Rao
Drazen M Jukic
Hong Wang
Janice M Shipe-Spotloe
John M Kirkwood
28 February 2008